- Home
- CRNX vs MRX Comparison
CRNX vs MRX Comparison
Compare CRNX & MRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- MRX
- Stock Information
- Founded
- CRNX 2008
- MRX 2005
- Country
- CRNX United States
- MRX United Kingdom
- Employees
- CRNX N/A
- MRX N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- MRX
- Sector
- CRNX Health Care
- MRX
- Exchange
- CRNX Nasdaq
- MRX NYSE
- Market Cap
- CRNX 2.8B
- MRX 2.8B
- IPO Year
- CRNX 2018
- MRX 2024
- Fundamental
- Price
- CRNX $31.75
- MRX $37.74
- Analyst Decision
- CRNX Strong Buy
- MRX Strong Buy
- Analyst Count
- CRNX 8
- MRX 6
- Target Price
- CRNX $74.86
- MRX $43.50
- AVG Volume (30 Days)
- CRNX 725.8K
- MRX 1.6M
- Earning Date
- CRNX 08-07-2025
- MRX 05-15-2025
- Dividend Yield
- CRNX N/A
- MRX 1.59%
- EPS Growth
- CRNX N/A
- MRX N/A
- EPS
- CRNX N/A
- MRX 3.09
- Revenue
- CRNX $760,000.00
- MRX $2,529,500,000.00
- Revenue This Year
- CRNX $402.02
- MRX N/A
- Revenue Next Year
- CRNX $771.03
- MRX $7.01
- P/E Ratio
- CRNX N/A
- MRX $12.24
- Revenue Growth
- CRNX N/A
- MRX 36.81
- 52 Week Low
- CRNX $24.10
- MRX $18.13
- 52 Week High
- CRNX $62.53
- MRX $49.34
- Technical
- Relative Strength Index (RSI)
- CRNX 57.94
- MRX N/A
- Support Level
- CRNX $28.98
- MRX N/A
- Resistance Level
- CRNX $32.49
- MRX N/A
- Average True Range (ATR)
- CRNX 1.24
- MRX 0.00
- MACD
- CRNX 0.30
- MRX 0.00
- Stochastic Oscillator
- CRNX 90.54
- MRX 0.00
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About MRX MAREX GROUP PLC
Marex Group PLC offers a diversified financial services platform providing essential liquidity, market access, and infrastructure services to clients across energy, commodities, and financial markets. It provides critical services to the clients by connecting them to exchanges and providing various execution and hedging services across its assets and products. The group operates in a large and fragmented market with infrastructure requirements and regulatory and technological complexity. It has five segments Clearing, Agency and Execution, Market Making, Hedging and Investment Solutions, and The Corporate. The group generates revenue from Agency and Execution that matches buyers and sellers by facilitating price discovery across the energy and financial securities markets.